A New Era: Immunotherapy Applied to Contemporary Cardiovascular Practice
Can J Cardiol
.
2022 Oct;38(10):1629-1633.
doi: 10.1016/j.cjca.2022.05.013.
Epub 2022 May 19.
Authors
Sabin Filimon
1
,
Cristina Pop
2
,
Michael Chetrit
1
,
Khashayar Esfahani
3
,
Marie Hudson
4
,
Jean Rouleau
5
,
George Thanassoulis
1
,
Eileen O'Meara
5
,
Nadia Bouabdallaoui
5
,
Caroline Michel
6
,
Haya Aziz
1
,
Phil Gold
7
,
Jean-Claude Tardif
5
,
Thao Huynh
8
Affiliations
1
McGill University Health Center, Division of Cardiology, Montréal, Québec, Canada.
2
McGill University Health Center, Division of Internal Medicine, Montréal, Québec, Canada.
3
Sir Mortimer B. Davis Jewish General Hospital, Division of Oncology, McGill University, Montréal, Québec, Canada.
4
Sir Mortimer B. Davis Jewish General Hospital, Division of Rheumatology, McGill University, Montréal, Québec, Canada.
5
Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
6
Sir Mortimer B. Davis Jewish General Hospital, Division of Cardiology, McGill University, Montréal, Québec, Canada.
7
McGill University, Faculty of Medicine and Health Sciences, Gerald Bronfman Department of Oncology, Montréal, Québec, Canada.
8
McGill University Health Center, Division of Cardiology, Montréal, Québec, Canada. Electronic address: thao.huynhthanh@mcgill.ca.
PMID:
35598801
DOI:
10.1016/j.cjca.2022.05.013
No abstract available
MeSH terms
Carcinoma, Renal Cell*
Humans
Immunologic Factors
Immunotherapy
Kidney Neoplasms*
Substances
Immunologic Factors